[Combined therapy of chronic hepatitis C in children with phosphogliv].
Two schemes of the treatment of chronic hepatitis C were compared. Each scheme included 40 medical treatment for 2 months. 22 patients received basic therapy including phosphogliv, 3-5 procedures of ultraviolet irradiation of blood (UVIB) and referon (the course was begun after the 2-nd procedure of UVIB). 18 patients received basic therapy with phosphogliv, UVIB and T-activin (the course also was begun after the second procedure of UVIB). The patients were observed for 9 months. An advantage of the combination of phosphogliv, UVIB and referon, providing a stable remission in 36.3% of the patients for 9 months was demonstrated.
Mukhamedov
N B
NB
Research Institute of Pediatrics, Talant, 3, Street, Chimbay-2, Tashkent, Uzbekistan.
Inoiatova
F I
FI
Aripov
A N
AN
Aripov
O A
OA
D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use*; D001769:Blood; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005260:Female; D019695:Glycyrrhizic Acid / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D014466:Ultraviolet Rays
D000998:Antiviral Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D019695:Glycyrrhizic Acid